期刊文献+

前列腺癌易感性与丝裂原活化蛋白激酶激酶4基因多态性的关系

Associations between-1304 T 〉 G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and prostate cancer susceptibility
原文传递
导出
摘要 目的探讨苏皖地区汉族人群中丝裂原活化蛋白激酶激酶4(MKK4)基因多态性与前列腺癌(PCa)易感性的关系。方法采用病例对照研究,提取174例PCa患者和252例健康人(对照组)外周血基因组DNA,应用聚合酶链反应-连接酶特异检测技术(PCR—LDR)分析PCa患者和对照组MKK4基因-1304位点的多态性,比较不同基因型与PCa易感性的关系,并探讨吸烟、饮酒等因素在其中的影响。结果MKK4基因启动子区存在1个SNP位点(-1304T〉G),基因型分别为TT型、TG型和GG型;Logistic回归分析显示,携带TG、GG和TG+GG基因型的个体与PCa发病风险之间无明皿相关性[比值比(OR)=0.775,95%可信区间(CI)=0.516~1.164;OR=0.650,95%CI=0.216~1.956;OR=0.763,95%CI=0.514~1.135]。在高龄(〉70岁)和非饮酒人群中,TG+GG基因型的个体发病率明显减少,调整后的OR(95%CI)分别为0.575(0.348~0.951)、0.477(0.252~0.906)。结论苏皖地区汉族人群中MKK4基因-1304位点基因多态性对PCa易感性无明显影响. Objective To investigate the associations between-1304T 〉 G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 (MKK4) gene and prostate cancer (PCa) susceptibility in the 1tan population in Jiangsu and Anhui. Methods A case control experiment was performed, consisting of 174 cases of newly diagnosed PCa and 252 cancer-free healthy controls. The peripheral blood genome DNA was extracted. The polymorphism of MKK4-1304 locus was analyzed by polymerase chain reaction-ligase detection reaction (PCR-LDR) technique. The associations between the susceptibility to PCa and different genotypes were compared. Results TF, TG, and GG genotypes were identified in the pro- moter of MKK4 gene (-1304T/G). Logistic regression analysis revealed there was no significant difference at MKK4-1304 site between TG, GG, and TG + GG genotypes and TF genotype (OR = 0. 775, 95% CI = 0. 516-1. 164; OR =0. 650, 95% CI =0. 216-1. 956; OR =0. 763, 95% CI =0. 514-1. 135, respectively). However, in the stratification analysis, the decreased risk of PCa was associated with the-1304G variant genotypes ( -1304TG/GG), particularly in the subgroups of subjects older than 70 years ( OR = 0. 575, 95% CI = 0. 348-0. 951 ) and no-smokers ( OR = 0. 477, 95% CI = 0. 252-0. 906 ). Conclusion The MKK4-1304 polymorphism is not related directly to the susceptibility to PCa in the Han population in Jiangsu and Anhui.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第6期1062-1065,共4页 Chinese Journal of Experimental Surgery
基金 基金项目:江苏省科技厅基础研究计划项目(BK2010577)
关键词 前列腺癌 丝裂原活化蛋白激酶激酶4 基因多态性 Prostate carcinoma Mitogen-activated protein kinase kinase 4 Gene polymorphism
  • 相关文献

参考文献20

  • 1Jemal A,Siegel R,Ward E,et al. Cancer statistics. CA Cancer J Clin, 2006,56 : 106-130.
  • 2McCracken M, Olsen M, Chen MS Jr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin ,2007,57 : 190-205.
  • 3李鸣,张思维,马建辉,陈万青,那彦群.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂志,2009,30(6):368-370. 被引量:171
  • 4Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet ,2004,13 : 103-121.
  • 5Habuchi T, Suzuki T, Sasaki R, et al. Association of vitaminD receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res,2000,60:305-308.
  • 6Maruyama J, Naguro I, Takeda K, et al. Stress-activated MAP kinase cascades in cellular senescence. Curt Med Chem, 2009, 16 : 1229-1235.
  • 7Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature ,2001,410:37-40.
  • 8Cuenda A. Mitogen-activated protein kinase kinase 4 (MKK4). Int J Biochem Cell Bio1,2000,32:581-587.
  • 9Bin L,Dianke C,Lei Y,et al. A functional variant ( - 1304T > G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity. Carcinogenesis, 2010, 31: 1405-1411.
  • 10Yujiri T, Sather S, Fanger GR, et al. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science, 1998,282 : 1911-1914.

二级参考文献34

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部